🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our CSO Prof Robin Shattock was invited to a celebratory dinner to receive the Queen’s Anniversary Prize for the ‘world-class’ COVID-19 response at Imperial College London. Read article here: bit.ly/3BEcEfH #biotech #COVID

Great to see recent news featured in Science Magazine of solid top line Phase III results for ArcturusRx #COVID19 vaccine trial. This trial showed 95% efficacy in preventing severe disease, which validates #saRNA #vaccines.

Our Managing Director, Tim Sparey, will be attending the 22nd Bio€quity Europe 2022 in Milan, Italy from the 16th to the 18th of May 2022.The event is organised by BioCentury Inc. and EBD Group #saRNA #BioTech #conference #BioEquity

We are expanding at @CamSciencePark with 2,000 sq ft of lab space and welcome our new team members Rob Barber, Senior Director, Alliance Management and Conor Woolfson as Finance Director. Read the full release on our revamped new website: bit.ly/38lHj7k

We are looking to recruit an experienced and motivated RNA Development Scientist who will play a key role in developing our technology and establishing a pipeline of new vaccines and therapeutics. Apply here: vaxequity.bamboohr.com/jobs/view.php?… #saRNA #RNA

We are looking for an exceptional Senior Scientist who will be responsible for the design, research, and development of RNA formulations. Apply here: vaxequity.bamboohr.com/jobs/view.php?… #biotech #saRNA #RNA

We are looking for an exceptional Project Director to lead our Project and Program Management activities. Come and join us at the beginning of our exciting, scientific journey. Apply here: vaxequity.bamboohr.com/jobs/view.php?… #biotech #saRNA #RNA

Tim Sparey, our Managing Director, will be at the world’s largest bio-industry partnering event, #BIO2022. Connect with us to learn more about our self-amplifying #RNA platform. Link to the event: bit.ly/3ssKuRv

We are looking for ambitious & agile scientists to join our team in Cambridge to help create the next generation of self-amplifying RNA #vaccines & #therapeutics. Watch our new film here: vimeo.com/731309136 #recruitment #biotechjobs #biotech

It’s #RNAday! Take a moment to honour RNA, DNA’s close relative, and a fundamental building block of life as we know it. We’re working on self-amplifying RNA and mRNA therapeutics and vaccines. See: vaxequity.com #Biotech #RNA #therapeutics

Our Director, Dr Mike Watson, will speak at the ExcellGene Symposium in Lausanne on 30 August. The event brings together scientists, investors, and politicians to discuss #vaccine manufacturing challenges. See here: symposium.excellgene.com #biotech #lifesciences

Delighted to be highlighted by Jacob Bell BioPharma Dive in excellent feature on #biotech companies making next-gen #RNA technologies as new, longer-lasting, medicines with a broader reach. See here: biopharmadive.com/news/rna-next-… #lifesciences #vaccines #therapeutics

Our newly appointed Head of Drug Delivery and Formulation George Dakwar will attend the International mRNA Health Conference with Robin Shattock & Karnyart (Kay) Samnuan from 8-10 November. At the event, George, Robin and Kay will be sharing their self-amplifying RNA & mRNA #therapeutics expertise 👇

Our Managing Director Tim Sparey will take our self-amplifying RNA platform (saRNA) on the road to join #BiotechShowcase, one of the biggest #biotech and #lifesciences investor and networking conferences. Contact [email protected] to connect!

New #collaboration news: Innovate UK has awarded approximately £700,000 to our exciting new #partnership with CPI to help develop the #manufacturing process of innovative vaccines and treatments: vaxequity.com/news-and-event…

Today is #RNADay, celebrating the vital role RNA plays in sustaining life and improving medicines from COVID vaccines to gene editing. Check out our self-amplifying RNA technology at vaxequity.com #Biotech #Lifesciences #drugdiscovery #therapeutics #vaccines